1202757-89-8 Manufacturer Hot Sale 1202757-89-8 AVL 292 High Purity Spebrutinib CAS NO.1202757-89-8
- FOB Price: USD: /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: T/T,MoneyGram,Other
- Available Specifications:
99%(1-5)Gram98%(1-5)Gram
- Product Details
Keywords
- 1202757-89-8 Manufacturer
- Hot Sale 1202757-89-8 AVL 292
- High Purity Spebrutinib
Quick Details
- ProName: 1202757-89-8 Manufacturer Hot Sale 120...
- CasNo: 1202757-89-8
- Molecular Formula: C22H22FN5O3
- Appearance: Powder
- Application: Scientific research
- DeliveryTime: Prompt
- PackAge: As required
- Port: Shanghai
- ProductionCapacity: 1000 Gram/Week
- Purity: 98%
- Storage: keep sealed and keep from direct light
- Transportation: By Sea/Air/FedEx
- LimitNum: 1 Gram
- Moisture Content: N/A
- Impurity: N/A
- Grade: Industrial Grade,Pharma Grade
Superiority
1202757-89-8 Manufacturer Hot Sale 1202757-89-8 AVL 292 High Purity Spebrutinib
Spebrutinib, also known as AVL-292 or CC-292, is an orally bioavailable, selective inhibitor of BrutonÂ’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity. Upon administration, AVL-292 targets and covalently binds to BTK, thereby preventing its activity. By irreversibly inhibiting BTK, administration of this agent may lead to an inhibition of B cell receptor (BCR) signaling and may inhibit cell proliferation of B-cell malignancies.
Spebrutinib (CC-292) is a covalent, highly selective, orally active inhibitor of Btk with IC50 value of 0.5 nM. Spebrutinib also less potently inhibits Yes, c-Src, Brk, Lyn, and Fyn with IC50s of 723 nM, 1.729 μM, 2.43 μM, 4.4 μM, and 7.15 μM, rspectively. Extensive analysis has revealed that the EC50 of Btk occupancy from a Spebrutinib dose-response in Ramos cells (EC50=6 nM) correlated directly with the cellular EC50 of Btk kinase inhibition with Spebrutinib (EC50=8 nM). Furthermore, the concentration at which Spebrutinib inhibits 90% of Btk activity in Ramos cells is 35 nM while the concentration of Spebrutinib required for 90% occupancy of Btk is 39 nM
AVL-292 is a covalent inhibitor of Bruton’s tyrosine kinase (BTK; IC50 = 5.9 nM). It is selective for BTK over a panel of 61 kinases when used at a concentration of 1 µM but does inhibit the additional Tec family kinases BMX, Itk, Tec, and TXK (IC50s = 0.7, 36, 6.2, and 8.9 nM, respectively). AVL-292 inhibits naïve human B cell proliferation (EC50 = 3 nM). It reduces joint damage, pannus formation, cartilage degradation, and bone erosion in a mouse model of rheumatioid arthritis induced by collagen when used at doses of 3, 10, and 30 mg/kg.
Details
Alternate Name | N-(3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide; CC-292 |
---|---|
Appearance | White to off-white solid |
CAS # | 1202757-89-8 |
Molecular Formula | C??H??FN?O? |
Molecular Weight | 423.44 |
Purity | ≥98% by HPLC |
Solubility | DMSO (>50 mg/ml) |
SMILES | COCCOC1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)F |
InChi | InChI=1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28) |
InChi Key | KXBDTLQSDKGAEB-UHFFFAOYSA-N |
PubChem CID | 59174488 |
Handling | Protect from air and light |
Storage Conditions | -20°C |
Shipping Conditions | Gel Pack |